2-[(1R,3R)-1-acetyloxy-4-methyl-3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentyl]-1,3-thiazole-4-carboxylic acid
CAS No.:
Cat. No.: SC25887
Available on Request
Price on Request
Contact us for pricing, MOQ, and lead time
Product Name :2-[(1R,3R)-1-acetyloxy-4-methyl-3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentyl]-1,3-thiazole-4-carboxylic acid
Cat. No.: :SC25887
Purity / Specification :—
CAS No. :936691-36-0
MDL No. :—
Molecular Formula :C18H28N2O6S
LogP :3.20
Molecular Weight :400.49
TPSA :134.0
Category :API Intermediates
HSN Code :—
SMILES Code :CC(=O)O[C@H](C[C@H](C(C)C)N(C)C(=O)OC(C)(C)C)c1nc(C(=O)O)cs1
Melting Point :—
InChI Key : :ZDUQJTVUWQHXBF-ZIAGYGMSSA-N
Boiling Point :No data available
Application Note
AI GeneratedGenerated by AI. Verify before use in regulatory documents.
Lipinski & ADMET Properties
Computational estimateLipinski Rule of 5
iMW ≤ 500 Da✓ 400.5 Da
LogP ≤ 5✓ 3.20
HBD ≤ 5✓ 1
HBA ≤ 10✓ 8
Max 1 violation allowed for oral bioavailability.
Drug-likeness Score
i65/100
Moderate — typical building block
Predicted LogP
i3.20log units
Lipophilic
CNS Permeability
iClark model · J Pharm Sci, 1999
CNS− unlikely
TPSA 134.0Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−
Requires experimental confirmation.
⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.
